Every SEC Form 3/4/5 on record for this filer (CIK 1820278) — 7 issuers, 27 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | Director | 2025-06-06 → 2026-06-29 | 3 | — |
| GKOS | GLAUKOS Corp | Director | 2021-03-03 → 2026-06-23 | 13 | — |
| SPTX | Seaport Therapeutics, Inc. | Director | 2026-04-30 → 2026-05-04 | 2 | — |
| TSVT | 2seventy bio, Inc. | Director | 2021-10-18 → 2025-05-15 | 6 | — |
| KRTX | Karuna Therapeutics, Inc. | Director · lapsed | 2020-12-22 → 2024-03-18 | 6 | — |
| SURF | Surface Oncology, Inc. | Director · lapsed | 2021-07-08 → 2022-06-10 | 4 | — |
| BLUE | bluebird bio, Inc. | Director · lapsed | 2020-08-11 → 2021-11-17 | 4 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
3 of 7 issuers are covered and open a security page; the rest are on file here only.
